Christopher DelNagro

Christopher DelNagro has a long and varied work experience. Christopher began their career in 1992 as a Ph.D., MS, and BS Student at the University of California at San Diego. In 1995, they worked as a Research Associate at EGEN Pharmaceuticals. The following year, they worked as a Research Associate at La Jolla Pharmaceutical Company. In 2006, they joined Roche Pharmaceuticals as a Research Scientist in the Inflammation Division and a Post-doctoral Scientist. From 2009 to 2014, they worked as a Senior Scientific Researcher at Genentech. Christopher then moved to MedImmune as a Scientist II in 2014. In 2017, they joined AstraZeneca as a Senior Scientist and Translational Team Lead in Immuno-oncology. In 2019, they moved to Exelixis as a Director of Translational Medicine. In 2021, they joined Asher Biotherapeutics as the Head of Translational Science and Biomarkers, Sr. Director.

Christopher DelNagro received their Doctor of Philosophy (Ph.D.) in Biology from UC San Diego between 1999 and 2005. Christopher also earned their B.S. in Biology from UC San Diego between 1992 and 1997. In 2010 and 2011, they completed a Professional Certificate in Advanced Project Management from Stanford University. From 2009 to 2013, they earned a Professional Certificate in Life Science Business from University of California, Berkeley. Christopher also completed a Professional Certificate in Clinical Research Conduct and Management from University of California, Berkeley in 2012.